CTNNB1 and neoplasm: Thus, reprogrammed hepatocytes are an intermediate cell phenotype, reflecting tumor cell differentiation to normal hepatocyte-like cells and contributing to the rapid cell turnover observed following LNP-CTNNB1 treatment.